What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
The peptide does not act on the HPG axis, does not stimulate LH or FSH release, and does not bind to androgen receptors
History of pancreatitis or gallbladder disease, because these conditions may worsen with GLP-1 medications
Common Neurobion Forte Injection side effects can include injection site pain, redness, swelling, nausea, dizziness, headache, or mild stomach discomfort
However, allergic reactions are possible, although rare